N-glycan profi ling of therapeutic glycoproteins is essential to ensure the activity and effi cacy of these promising new-generation drugs. The N-linked glycan moieties of these entities highly affect circulation half-life, immunogenicity and receptor-binding activity as well as physicochemical and thermal stability properties. In addition, more than half of the biopharmaceuticals are glycoproteins representing multibillion dollar worldwide business, further emphasizing the importance of their analysis. In the biomedical fi eld, on the other hand, revealing disease-related glycan structure alterations holds the promise of the discovery of new biomarkers for early diagnostics. Therefore, there is a great demand for widely applicable, high-throughput sample preparation and analysis methods for N-glycan profi ling of glycoproteins. One of the newest exciting developments of the fi eld is the magnetic bead based glycoprotein sample preparation technique. A detailed protocol of this method is given in this chapter in conjunction with rapid capillary electrophoresis analysis of the prepared samples by laser induced fl uorescence detection (CE-LIF). N-glycans are digested by the endoglycosidase PNGase F and the released carbohydrates are labeled with the charged fl uorophore dye of aminopyrenetrisulfonate (APTS). Effective glycan capture by magnetic microparticles enabled fast, easily automated sample preparation both in individual (single vial) and 96-well plate formats, including excess dye removal. Rapid separation of APTS labeled IgG glycans is also shown utilizing an optimized CE-LIF protocol.
Introduction
N-glycosylation analysis is one of the fastest growing areas in the biopharmaceutical and biomedical fi elds [ 1 , 2 ] . Glycosylation of the expressed polypeptide chains, e.g., in humans it is mediated by more than 600 enzymes during complex co-translational and posttranslational modifi cation processes [ 3 ] resulting extensive micro-and macro-heterogeneity [ 4 ] . Actually, the true variability of glycan structures comes from the fact that posttranslational modifi cations are highly dependent on the surrounding environment, state of health, presence of inhibitors and suppressors, etc. Therefore, changes may occur frequently and rapidly. Thus, the analysis of disease-associated structural changes such as core and antennary fucosylation is key and may lead to glycan based biomarker development and personalized treatments [ 5 ] . As a matter of fact, precisely defi ning the position of this particular sugar residue is not easy, e.g., MS based methods are prone to in-source fucosylation rearrangement [ 6 ] . The biopharmaceutical industry represents another important segment that needs large scale N-glycosylation analysis methods. In 2015, glycosylated monoclonal antibodies represented almost half of the biotherapeutic drugs on the market with an estimated $70 billion dollar business worldwide [ 7 ] . It has been recognized that structural changes in the sugar moiety of therapeutic glycoproteins may signifi cantly modify their activity and effi cacy [ 8 ] , highlighting the importance of their characterization during the entire manufacturing process. Large scale automated glycosylation analysis is of particular interest in early stages of protein drug development, e.g., during clone selection where transfection can result in numerous expressed variants.
One of the most frequently used high resolution glycan analysis techniques is capillary electrophoresis (CE) with laser induced fl uorescence detection (LIF). CE separation is capable to differentiate glycans based on their molecular shape, even if their mass to charge ratio are exactly the same [ 9 ] . Due to the high sensitivity of the selective LIF detection method (only fl uorophore labeled species are detected), injection of picomolar sample amounts are usually suffi cient to acquire reliable data, and microliter sample volumes are enough for dozens or even hundreds of analyses [ 10 ] .
In this protocol a rapid magnetic bead based sample preparation workfl ow is introduced for high-throughput N-glycan analysis applications in conjunction with fast CE-LIF separation. The N-linked carbohydrates were released from the glycoproteins by PNGase F (peptide-N4-(N-acetyl-beta-glucosaminyl) asparagineamidase), a reliable and specifi c cleavage enzyme that works under simple and mild conditions. PNGase F cleaves the bond between the carbohydrate holding asparagine residue at the conserved consensus sequence of Asn-X-Ser/Thr (X is any amino acid except proline, serine, and threonine) and the innermost N-acetyl glucosamine of the trimannosyl chitobiose core [ 11 ] . The released glycans are captured by magnetic microparticles and tagged in situ on bead via reductive amination with 8-aminopyrene-1,3,6-trisulfonic acid (APTS). The labeling reaction is specifi c to the reductive end of the sugars, therefore, only one APTS molecule binds to one sugar molecule, allowing easy quantifi cation. More importantly, since the sugar ring at the reducing end opens up during the derivatization step [ 12 ] , no anomeric isomers are generated, such as might be the case in the so called instant labeling approaches. The excess fl uorophore dye is removed by the same magnetic beads that were used in the earlier glycan capture step. Optimal separation parameters were also developed for rapid CE-LIF analysis of the released, fl uorophore labeled and purifi ed sugars.
Materials
HPLC grade water should be used (18 MΩ cm at 25 °C) in all buffer and reagent preparations. Some parts of sample preparation should be done under fume hood wearing powder-free nitrile gloves, lab coat, and eyeglasses. Only use new disposable vials that are free from possible environmental carbohydrate contaminations.
1. 0.2 mL safety lock fl at cap PCR tubes (actual total volume is 350 μL).
2. Thermostat block to provide stable temperatures at 37 °C and 65 °C.
3. Vortex mixer.
4. Automata pipettors and disposable pipette tips (2, 20, 200 and 1000 μL sizes).
5. Miscellaneous labware for buffers and reagents.
6. Neodymium magnet or magnetic stand or magnetic plate.
7. Agencourt CleanSEQ magnetic microparticles (Beckman Coulter, Part #A29151).
8. 50 mM dithiothreitol (DTT) in water. Prepare the solution fresh before use.
9. 250 mM iodoacetamide (IAA) in water. Prepare the solution fresh before use.
10. 5 % sodium dodecyl sulfate (SDS) in water.
11. 0.5 % Nonidet P-40 (NP-40) in water.
12. Peptide-N-glycosidase F enzyme (PNGase F) (ProZyme, Part #GKE5006B).
13. 20 % acetic acid.
14. 8-aminopyrene-1,3,6-trisulfonic acid (APTS) (Beckman Coulter, Part #M501706).
15. 40 mM 8-aminopyrene-1,3,6-trisulfonic acid (APTS) in 20 % acetic acid.
16. 1 M sodium cyanoborohydride (NaBH 3 CN) in tetrahydrofuran (THF) (Sigma, Part #296813).
17. Acetonitrile (100 %, HPLC grade).
N-Glycan
Release, APTS Labeling and Cleanup 4. Add 10 μL of glycoprotein sample into the sample tube (1-10 mg/mL concentration).
5. Mix the sample with the beads using a vortex (10 s at maximum speed) ( see Note 2 ).
6. Prepare the denaturation solution by mixing 2 μL each of 50 mM of DTT, 250 mM of IAA, 5 % of SDS and 0.5 % of NP-40 solutions.
7. Pipette 4 μL of denaturation solution into the sample containing tube and incubate at 65 °C for 10 min (denaturation step).
8. Pipette 16 μL of 0.5 % of NP-40 and 1 μL of PNGase F enzyme (2.5 mU) to the sample and incubate at 50 °C for 1 h (deglycosylation step) ( see Note 3 ).
9. After the denaturation step, mix the sample using a vortex (10 s at maximum speed).
10. Pipette 210 μL of acetonitrile into the reaction vial (this step will result in 87.5 % fi nal acetonitrile concentration in the vial) for glycan capture and vortex the sample (10 s at maximum speed).
11. Wait for 1 min at room temperature.
CE-LIF Analysis of APTS Labeled N-Glycans

In Solution N-Glycan Release
12. Place the sample tube on a magnetic stand and after the beads are pulled to the side of the vial (30 s), remove the supernatant by pipetting carefully ( see Notes 4 and 5 ).
1. Add 9 μL of 40 mM APTS ( fl uorophore ) in 20 % acetic acid (catalyst) to the reaction vial containing the magnetic beads with the captured glycans from step 12 in Subheading 3.1 .
2. Pipette 1 μL of 1 M NaBH 3 CN in THF (reductive agent) and 1 μL of 0.5 % NP-40 to the vial. Please note that the use of more NaBH 3 CN will not increase reaction speed.
3. Mix the sample using a vortex (10 s at maximum speed).
4. Incubate the reaction mixture at 37 °C for 2 h (labeling step).
1. After the labeling reaction, pipette 9 μL of 0.5 % NP-40 solution to the reaction tube and mix using a vortex (10 s at maximum speed) ( see Note 6 ).
2. Add 150 μL of acetonitrile and vortex the sample at maximum speed for 10 s.
3. Wait 1 min at room temperature.
4. Place the sample tube on a magnetic stand and after the beads are pulled to the side of the vial (30 s), remove the supernatant by pipetting carefully.
5. Repeat steps 1 -4 three more times using 20 μL HPLC grade water and 150 μL acetonitrile in each step.
6. After the fi nal supernatant removal, elute the labeled glycans from the beads by the addition of 50 μL of HPLC grade water and vortexing at maximum speed for 10 s.
7. Place the sample tube on a magnetic stand and after the beads are pulled to the side of the vial (30 s), transfer the supernatant (this contains the APTS labeled and purifi ed sugars) into a CE sample vial by pipetting carefully.
1. Weight out 5 mg of maltooligosaccharide ladder standard (SCIEX, part #M405039).
2. Label the ladder standard similar as was described under Subheading 3.2 . There is no need for excess APTS dye removal in this case due to the high sugar to dye ratio.
3. Stop the reaction by the addition of 90 μL of HPLC grade water.
4. Aliquot the APTS labeled maltooligosaccharide ladder sample into 10 μL portions and store at −20 °C.
5. Dilute the maltooligosaccharide ladder standard sample with HPLC grade water by 1000× before use in CE-LIF analysis.
APTS Labeling
Removal of the Excess APTS Dye
CE-LIF Analysis of the APTS Labeled N-Glycans
Preparation of the Glucose Ladder and Setting Up the CE-LIF Equipment
6. Transfer the APTS labeled samples and APTS labeled maltooligosaccharide ladder standard into CE sample vials. Place the sample vials in universal buffer vials and cap them.
Fill universal buffer vials with the following reagents:
(a) Three vials by 1.5 mL of HPLC grade water. Place two vials at home positions and one for capillary fi ll position.
(b) 1.5 mL N-linked carbohydrate separation gel buffer into one vial (capillary refi ll) and 1.3 mL N-linked carbohydrate separation gel buffer into two vials (separation).
(c) 0.5 mL of HPLC grade water into a waste vial (one universal buffer vial). (b) Electrokinetic injection (fi eld enhanced):
• Inject water at 1 psi for 5 s (forward).
• Inject sample at 2 kV for 2 s using the separation gel buffer at the outlet end of the capillary in reversed polarity mode (cathode at the injection side and the anode at the detection side).
• Inject separation gel buffer at 1 psi for 5 s (forward).
4. Wash the tip of the capillary by moving the trays into home position (universal buffer vials fi lled with HPLC grade water).
5. Separation: Apply 30 kV for 3 min in reversed polarity mode (cathode at the injection side and the anode at the detection side) with 5 psi pressure applied at both sides of the capillary .
6. Set autozero at 0.5 min.
7. End method by moving the trays to home position.
8. A rapid separation example of APTS labeled glycans from human IgG (Sigma Aldrich, Part #I4506) is shown in Fig. 1 ( see Note 7 ).
Performing Rapid CE-LIF Analysis
Notes
1. Avoid touching the beads with the pipette tips to prevent bead/sample loss.
2. Beads are easy to resuspend in aqueous solutions but diffi cult in organics because of possible aggregation, e.g., during the acetonitrile mediated glycan capture step. Therefore, always vigorously resuspend the beads before acetonitrile addition.
3. No mixing is necessary during the deglycosylation and labeling steps.
4. Always pipette the supernatant from the bottom of the vials as in this case non-captured beads, which might be fl oating in the upper segment of the vials, will not be accidentally removed.
5. Use the magnets (or stand) only for the minimum time required during buffer exchange to avoid possible bead aggregation.
6. Max speed vortexing in manual sample preparation mode may push some of the sample up to the microvial cap. Applying a quick (few seconds) spin-down in a small microcentrifuge can solve the issue and prevents any potential sample loss.
7. GU unit calculation software is freely available at: www.gucal.hu . 
